AC-203

N/A

Report date: 2024/03/18 20:07:11
NME

Base Information

Drug NameAC-203
Drug Alias NameAC-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicSpherocytosis, HereditaryAnemia, Aplastic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAccro Bioscience (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAccro Bioscience (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicSpherocytosis, HereditaryAnemia, Aplastic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A